Table 1.
Characteristics of studies included in the metastasis meta-analysis.
| References | Region | Total subjects (Male/Female) | Testing methods | β-catenin Cut-off | β-catenin positive | β-catenin negative | HR estimation | HR(95%CI) OS | Survival | NOS scores | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metastasis | Total | Metastasis | Total | |||||||||
| Lu et al. (17) | China | 96 (52/44) | IHC | >4 score | 42 | 59 | 13 | 37 | Sur-curve | 2.06 (1.11–3.85) | OS | 6 |
| Haydon et al. (13) | USA | 47 (28/19) | IHC | >0% | 5 | 33 | 3 | 14 | NA | NA | NA | 7 |
| Bao et al. (18) | China | 108 (67/41) | IHC | >4 score | 52 | 62 | 7 | 46 | Sur-curve | 6.36 (1.31–30.86) | OS | 5 |
| Deng et al. (19) | China | 90 (53/37) | IHC | >6 score | 37 | 54 | 13 | 36 | Sur-curve | 2.88 (1.35–6.13) | OS | 6 |
| Yi et al. (22) | China | 36 (20/16) | IHC | >10% | 11 | 27 | 2 | 9 | Sur-curve | 0.36 (0.05–2.59) | OS | 7 |
| Bi et al. (21) | China | 54 (30/24) | IHC | >10% | 15 | 37 | 6 | 17 | NA | NA | NA | 5 |
| Li et al. (20) | China | 35 (21/14) | IHC | >0% | 15 | 20 | 3 | 15 | NA | NA | NA | 7 |
| Liu (23) | China | 55 (38/17) | IHC | >1 score | 13 | 41 | 0 | 14 | NA | NA | NA | 6 |
IHC, immunohistochemistry; NA, not applicable; NOS, Newcastle–Ottawa Scale; OS, overall survival.